Key result
Novel PRKAR1A mutation causes Carney complex presenting with recurrent atrial myxoma and acromegaly.
Case Report (n=1)
No
Identifies a novel deleterious 22 bp insertion mutation in PRKAR1A causing Carney complex presenting with recurrent atrial myxoma, acromegaly, and male infertility without Sertoli cell tumors, underscoring the need for endocrine evaluation and familial genetic screening in patients with cardiac myxomas.
Answers are grounded in this paper and cite their sources.
May prompt endocrine evaluation in recurrent myxoma; extends PRKAR1A mutation spectrum in Carney complex.
UNLABELLED: Carney complex (CNC) is a rare autosomal dominant syndrome characterized by pigmented lesions of the skin and mucosae along with cardiac, endocrine, cutaneous, and neural myxomatous tumors. Mutations in the PRKAR1A gene have been identified in ∼70% of the CNC cases reported worldwide. A 30-year-old male was referred to the endocrinology clinic with suspected acromegaly. He had a history of recurrent atrial myxoma for the past 8 years for which he underwent repeated surgeries. Presently, he complained of having headache, excessive snoring, sweating, and also noticed increase in his shoe size. Evaluation for acromegaly revealed elevated levels of GH in random as well as in suppressed condition. Magnetic resonance imaging scan revealed enlarged sella with microadenoma in the left anterior pituitary. Screening of PRKAR1A gene was carried out for the patient, his parents and siblings who were available and willing to undergo the test. The patient was diagnosed to have the rare CNC syndrome characterized by recurrent atrial myxoma and acromegaly due to a novel 22 bp insertion mutation in PRKAR1A which was predicted to be deleterious by in silico analysis. Screening the available family members revealed the absence of this mutation in them except the elder brother who also tested positive for this mutation. The present study reports on a novel PRKAR1A insertion mutation in a patient with acromegaly and left atrial myxoma in CNC. LEARNING POINTS: Identification of a novel deleterious PRKAR1A insertion mutation causing CNC.It is important that patients with cardiac myxoma be investigated for presence of endocrine overactivity suggestive of CNC.PRKAR1A mutation analysis should be undertaken in such cases to confirm the diagnosis in the patients as well as first degree relatives.This case highlights an important aspect of diagnosis, clinical course, and management of this rare condition.
No takes yet. Share an insight, caveat, or question.
Birla et al. (2014) conducted a case report in Carney complex with recurrent left atrial myxoma and acromegaly (n=1). PRKAR1A gene sequencing and transnasal transsphenoidal pituitary surgery was evaluated on Identification of PRKAR1A mutation and biochemical remission of acromegaly. Direct sequencing of PRKAR1A identified a novel deleterious heterozygous 22 bp insertion mutation in exon 6 causing Carney complex with recurrent left atrial myxoma and acromegaly.
Synapse has enriched 10 related papers. Consider them for comparative context: